FUELING THE FUTURE: CinCor completes $143M round | Fintech IPO | Research grants

  • CINCINNATI, OH—CinCor announced the completion of a $143 million Series B financing round. This will support the continued development of a treatment for hypertension, primary aldosteronism and chronic kidney disease. The financing was led by General Atlantic, with participation from new investors Perceptive Advisors, BVF Partners, venBio Partners, Adage Capital Management, Omega Funds, Rock Springs Capital, RTW Investments, Lilly Asia Ventures and Sixty Degree Capital.